368 related articles for article (PubMed ID: 24012326)
1. Progress update: fluid and imaging biomarkers in Alzheimer's disease.
Sutphen CL; Fagan AM; Holtzman DM
Biol Psychiatry; 2014 Apr; 75(7):520-6. PubMed ID: 24012326
[TBL] [Abstract][Full Text] [Related]
2. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.
Trojanowski JQ; Vandeerstichele H; Korecka M; Clark CM; Aisen PS; Petersen RC; Blennow K; Soares H; Simon A; Lewczuk P; Dean R; Siemers E; Potter WZ; Weiner MW; Jack CR; Jagust W; Toga AW; Lee VM; Shaw LM;
Alzheimers Dement; 2010 May; 6(3):230-8. PubMed ID: 20451871
[TBL] [Abstract][Full Text] [Related]
3. Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection.
Risacher SL; Saykin AJ
Annu Rev Clin Psychol; 2013; 9():621-48. PubMed ID: 23297785
[TBL] [Abstract][Full Text] [Related]
4. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
[TBL] [Abstract][Full Text] [Related]
5. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
Lista S; Garaci FG; Ewers M; Teipel S; Zetterberg H; Blennow K; Hampel H
Alzheimers Dement; 2014 May; 10(3):381-92. PubMed ID: 23850330
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.
Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G
J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136
[TBL] [Abstract][Full Text] [Related]
7. Neuroimaging for Early Diagnosis of Alzheimer's Disease: a Review.
Ou CH; Liu TJ; Cheng CS; Lin PL; Lee CL
Clin Lab; 2024 Jun; 70(6):. PubMed ID: 38868886
[TBL] [Abstract][Full Text] [Related]
8. [Biomarkers of Alzheimer's disease in older and oldest old patients].
Lilamand M; Cognat E; Goutagny S; Hourregue C; Hugon J; Dumurgier J; Paquet C
Geriatr Psychol Neuropsychiatr Vieil; 2019 Mar; 17(1):65-72. PubMed ID: 30907369
[TBL] [Abstract][Full Text] [Related]
9. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in preclinical Alzheimer's disease.
Chong MS; Lim WS; Sahadevan S
Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
[TBL] [Abstract][Full Text] [Related]
11. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
Pérez-Grijalba V; Romero J; Pesini P; Sarasa L; Monleón I; San-José I; Arbizu J; Martínez-Lage P; Munuera J; Ruiz A; Tárraga L; Boada M; Sarasa M
J Prev Alzheimers Dis; 2019; 6(1):34-41. PubMed ID: 30569084
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.
Schaffer C; Sarad N; DeCrumpe A; Goswami D; Herrmann S; Morales J; Patel P; Osborne J
J Lab Autom; 2015 Oct; 20(5):589-600. PubMed ID: 25424384
[TBL] [Abstract][Full Text] [Related]
13. Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease.
Yu X; Shao K; Wan K; Li T; Li Y; Zhu X; Han Y
Chin Med J (Engl); 2023 Mar; 136(5):505-521. PubMed ID: 36914945
[TBL] [Abstract][Full Text] [Related]
14. Fluid biomarkers in Alzheimer's disease - current concepts.
Rosén C; Hansson O; Blennow K; Zetterberg H
Mol Neurodegener; 2013 Jun; 8():20. PubMed ID: 23800368
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for Alzheimer's disease. Where we stand and where we are headed.
Chrem Mendez P; Surace E; Bérgamo Y; Calandri I; Vázquez S; Sevlever G; Allegri RF
Medicina (B Aires); 2019; 79(Spec 6/1):546-551. PubMed ID: 31864224
[TBL] [Abstract][Full Text] [Related]
16. Biomarker modelling of early molecular changes in Alzheimer's disease.
Paterson RW; Toombs J; Slattery CF; Schott JM; Zetterberg H
Mol Diagn Ther; 2014 Apr; 18(2):213-27. PubMed ID: 24281842
[TBL] [Abstract][Full Text] [Related]
17. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
[TBL] [Abstract][Full Text] [Related]
18. Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.
Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Yu Z
Mol Med Rep; 2016 Oct; 14(4):3184-98. PubMed ID: 27511317
[TBL] [Abstract][Full Text] [Related]
19. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
[TBL] [Abstract][Full Text] [Related]
20. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2012 Feb; 8(1 Suppl):S1-68. PubMed ID: 22047634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
